351
Views
6
CrossRef citations to date
0
Altmetric
Review

Strategies for decision-making on vaccine use: the French experience

, &

References

  • Van Panhuis WG, Grefenstette J, Jung SY, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med 2013;369(22):2152-8
  • Wicker S, Maltezou HC. Vaccine-preventable diseases in Europe: where do we stand? Expert Rev Vaccines 2014;13(8):979-87
  • Stahl JP, Cohen R, Denis F, et al. Vaccination against meningococcus C. vaccinal coverage in the French target population. Médecine Mal Infect 2013;43(2):75-80
  • Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298(18):2155-63
  • Rodwin VG. The health care system under French national health insurance: lessons for health reform in the United States. Am J Public Health 2003;93(1):31-7
  • Floret D, Deutsch P. The french technical vaccination committee (CTV). Vaccine 2010;28(Suppl 1):A42-7
  • Programme national d’amelioration de la politique vaccinale 2012-2017 [Internet]. Available from: http://www.sante.gouv.fr/IMG/pdf/programme_national_d_amelioration_de_la_politique_vaccinale_2012-2017_2_.pdf [Last accessed 15 January 2015]
  • Taha MK. Immunisation against meningococcus B. Lancet 2013;382(9896):936
  • Caseris M, Houhou N, Longuet P, et al. French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital. Clin Microbiol Infect 2014;20(4):O242-4
  • Flicoteaux R, Pulcini C, Carrieri P, et al. Correlates of general practitioners’ recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns. Vaccine 2014;32(20):2281-7
  • Laurent-Ledru V, Thomson A, Monsonego J. Civil society: a critical new advocate for vaccination in Europe. Vaccine 2011;29(4):624-8
  • Poland GA, Spier R. Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health. Vaccine 2010;28(12):2361-2
  • Lewis J, Speers T. Misleading media reporting? The MMR story. Nat Rev Immunol 2003;3(11):913-18
  • Caseris M, Burdet C, Lepeule R, et al. An update on measles. Rev Med Interne 2015. [Epub ahead of print]
  • Denis F, Cohen R, Martinot A, et al. Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011. Médecine Mal Infect 2013;43(7):272-8
  • Fagot JP, Boutrelle A, Ricordeau P, et al. HPV vaccination in France: uptake, costs and issues for the national health insurance. Vaccine 2011;29(19):3610-16
  • Bellia C, Setbon M, Zylberman P, et al. Healthcare worker compliance with seasonal and pandemic influenza vaccination. Influenza Other Respir Viruses 2013;7(Suppl 2):97-104
  • Maltezou HC, Maragos A, Katerelos P, et al. Influenza vaccination acceptance among health-care workers: a nationwide survey. Vaccine 2008;26(11):1408-10
  • Freund R, Krivine A, Prévost V, et al. Measles immunity and measles vaccine acceptance among healthcare workers in Paris, France. J Hosp Infect 2013;84(1):38-43
  • Loulergue P, Guthmann J-P, Fonteneau L, et al. Susceptibility of health care students to measles, Paris, France. Emerg Infect Dis 2011;17(9):1766-7
  • Loulergue P, Fonteneau L, Armengaud JB, et al. Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. Vaccine 2013;31(26):2835-8
  • Russi M, Behrman A, Buchta WG, et al. Pertussis vaccination of health care workers: ACOEM medical center occupational health section task force on pertussis vaccination of health care workers. J Occup Environ Med 2013;55(9):1113-15
  • Loulergue P, Launay O. Vaccinations among medical and nursing students: coverage and opportunities. Vaccine 2014;32(38):4855-9
  • Loulergue P, Mir O, Alexandre J, et al. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008;19(9):1658

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.